KalVista Pharmaceuticals Aktie
14,30
EUR
+0,90
EUR
+6,72
%
16,43
USD
+0,84
USD
+5,39
%
Werbung
KalVista Pharmaceuticals Aktie Analyse
| 20.03.19 | KalVista Pharmaceuticals Buy | Needham & Company, LLC | |
| 21.09.18 | KalVista Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 31.08.17 | KalVista Pharmaceuticals Buy | BTIG Research |
Werbung
Werbung